Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bivalent HPV-16/18 vaccine versus hepatitis A vaccine control in healthy young women
2004-001325-14Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human papillomavirus type 16 L1 capsid protein antigen and Hepatitis A virus vaccine in human papillomavirus infection and Cervical Cancer (CC) (2 arms), sponsored by GSK. Started Apr 2010; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenHepatitis A virus vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on 2004-001325-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001325-14.